Drug Reduction in Older Patients: The DROP Trial

NACompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

October 7, 2019

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Geriatric AssessmentFrail ElderlySkilled Nursing FacilitiesPatient-centered Care
Interventions
OTHER

Deprescribing intervention

"In addition to a medication history, a study Pharmacist or Nurse Practitioner will review the reconciled total enrollment medication list. The following information will be ascertained for each medication: (1) Medication Indication; and, (2) Deprescribing rationale: Rationales for deprescribing (i.e., stopping or reducing dose) will be assessed for each medication.~Deprescribing Recommendations: For each medication recommended for deprescribing, the deprescribing action will be specified as: (1) Stop prior to hospital discharge without need for monitoring; (2) Stop prior to hospital discharge with symptoms/physiologic monitoring; (3) Stop at specified time point following hospital discharge; (4) Reduce over time with monitoring until medication is stopped; (5) Reduce to lower dose without need for monitoring; (6) Reduce to lower dose with symptoms/physiologic monitoring."

Trial Locations (1)

37212-2637

Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT03722017 - Drug Reduction in Older Patients: The DROP Trial | Biotech Hunter | Biotech Hunter